MedPath

Pharmaceutical Companies

Celularity, Inc. logo

Celularity, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2017-09-01
Employees
225
Market Cap
$66.1M
Website
http://www.celularity.com

Affimed NV

๐Ÿ‡ฉ๐Ÿ‡ชGermany
Ownership
-
Established
-
Employees
78
Market Cap
$63.9M
Website
-
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The companyโ€™s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of...
Entera Bio, Inc. logo

Entera Bio, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2010-01-01
Employees
37
Market Cap
$62.4M
Website
http://www.enterabio.com
Allakos Inc. logo

Allakos Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2012-01-01
Employees
131
Market Cap
$62.1M
Website
http://www.allakos.com
Actinium logo

Actinium

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2000-01-01
Employees
49
Market Cap
$61.9M
Website
http://www.actiniumpharma.com
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was...
EAGLE PHARMACEUTICALS logo

EAGLE PHARMACEUTICALS

๐Ÿ‡ฎ๐Ÿ‡ณIndia
Ownership
Public
Established
2007-01-01
Employees
135
Market Cap
$61.6M
Website
http://www.eagleus.com

Vor Biopharma

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
-
Employees
168
Market Cap
$60.8M
Website
-
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients...
Kronos Bio logo

Kronos Bio

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2017-01-01
Employees
62
Market Cap
$60.1M
Website
http://www.kronosbio.com
Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by...
Immix Biopharma logo

Immix Biopharma

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Public
Established
2012-01-01
Employees
17
Market Cap
$59.8M
Website
http://www.immixbio.com
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is...
Theratechnologies, Inc. logo

Theratechnologies, Inc.

๐Ÿ‡จ๐Ÿ‡ฆCanada
Ownership
Public
Established
1993-01-01
Employees
114
Market Cap
$59.7M
Website
http://www.theratech.com
ยฉ Copyright 2025. All Rights Reserved by MedPath